Periodontal disease, not otherwise specified
Conditions
Interventions
Treatment Methods: 40 patients with dental implant disease under similar conditions will be selected. Of these, 20 patients will be assigned to group A (control) and another 20 patients to group B (te
K05.6
Sponsors
Universidade do Estado do Rio de Janeiro
Universidade do Estado do Rio de Janeiro
Eligibility
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Included patients must have gingival bleeding around the implant, bone loss around the implant and the implant must have been in masticatory function for more than 01 year, patient of both sexes aged between 18 and 80 years, non-smokers, not using of systemic medication and patients should not be pregnant or lactating.
Exclusion criteria
Exclusion criteria: Excluded patients must not present: gingival bleeding around the implant, bone loss around the implant and the implant must not have been in mastication for more than 01 year, aged below 18 years or above 80 years, smokers, with use of systemic medication and pregnant and lactating patients, history of alcohol or drug abuse; diagnoses of cardiac, renal, gastrointestinal, hepatic, pulmonary, neurological, psychiatric, hematological or metabolic pathologies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Peri-implant therapy with surgical access for scaling with or without the use of photodynamic therapy and 0.2% toluidine blue reagent resulted in similar improvement in clinical parameters in both groups. Bone levels remained stable after one year of treatment in both groups. Interleukin 6 and Osteocalcin levels were significantly reduced in the test and control groups after 1 year of treatment. In the test group there was a significant reduction in Leptin. | — |
Countries
Brazil
Contacts
Public ContactGuilherme Moura
Universidade do Estado do Rio de Janeiro
Outcome results
None listed